Home
Stock screener
Insider screener
Rankings
Watchlist
Sign in
Create account
Stocks
·
Health care
· Pharmaceutical Preparations
CRNX
Crinetics Pharmaceuticals, Inc.
CRNX
Clue Score
54
United States
Fiscal year ends December
CIK 0001658247
Results filed 3 Aug 2026
Add to watchlist
Overview
Financials
Insiders
Summary
By person
Transactions
What the insiders did
Net buying
1 month
12 months
120 months
By person
22 insiders · 216 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Perceptive Advisors LLC
entity
10% owner
$54.06M
(5)
—
+$54.06M
5,321,032
5.02%
$212.84M
+1,630%
Richard Scott Struthers
President & CEO
$65.00K
(2)
$23.19M
(23)
scheduled
−$23.12M
111,100
0.1047%
$4.44M
−91.6%
Vivo Capital VIII, LLC
entity
10% owner
$6.58M
(4)
$19.81M
(34)
−$13.24M
298,625
0.2815%
$11.95M
—
5AM Ventures IV, L.P.
entity
Former 10% holder
$1.96M
(2)
$15.04M
(6)
−$13.08M
94,489
0.0891%
$3.78M
—
Stephen F. Betz
Chief Scientific Officer
—
$8.75M
(53)
scheduled
−$8.75M
0
0.0000%
$0.00
−100.0%
Dana Pizzuti
Chief Med and Dev Officer
—
$7.11M
(21)
scheduled
−$7.11M
66,837
0.0630%
$2.67M
+1,584%
Jeff E. Knight
Chief Dev. & Operating Officer
—
$7.04M
(11)
scheduled
−$7.04M
105,289
0.0993%
$4.21M
+2,375%
Marc Wilson
CFO
—
$6.64M
(9)
scheduled
−$6.64M
111,092
0.1047%
$4.44M
+69.9%
Matthew K Fust
Director
—
$4.24M
(12)
scheduled
−$4.24M
0
0.0000%
$0.00
−100.0%
James Hassard
Chief Commercial Officer
—
$1.33M
(2)
scheduled
−$1.33M
29,259
0.0276%
$1.17M
—
Stephanie Okey
Director
—
$1.18M
(4)
scheduled
−$1.18M
0
0.0000%
$0.00
—
Ajay Madan
Chief Development Officer
—
$418.00K
(2)
−$418.00K
176,995
0.1669%
$7.08M
+189.8%
Alan Seth Krasner
Chief Medical Officer
$34.00K
(1)
$352.08K
(2)
scheduled
−$318.08K
43,210
0.0407%
$1.73M
+372.4%
Tobin Schilke
Chief Financial & Infra. Ofcr.
—
$266.30K
(1)
scheduled
−$266.30K
0
0.0000%
$0.00
−100.0%
Coelho Rogerio Vivaldi
Director
$110.30K
(1)
$300.76K
(3)
scheduled
−$190.46K
0
0.0000%
$0.00
—
Isabel Kalofonos
Chief Commercial Officer
—
$137.50K
(1)
scheduled
−$137.50K
0
0.0000%
$0.00
−100.0%
Wendall Wierenga
Director
—
—
—
116,146
0.1095%
$4.65M
+55.9%
Wendell Wierenga
Director
—
—
—
0
0.0000%
$0.00
−100.0%
Caren Deardorf
Director
—
—
—
0
0.0000%
$0.00
—
Weston Nichols
Director
—
—
—
0
0.0000%
$0.00
—
Camille L Bedrosian
Director
—
—
—
0
0.0000%
$0.00
—
Versant Venture Capital V, L.P.
entity
10% owner
—
—
—
0
0.0000%
$0.00
—
